Regain begins within 2 to 3 weeks of last dose Appetite returns to pre-treatment levels or higher (rebound hyperphagia) Weight regain of 1 to 2 pounds per week for the first 8 to 12 weeks Patients report feeling "more hungry than before I started" Typically occurs in patients who made minimal dietary or behavioral changes during treatment Regain trajectory matches or exceeds the STEP 1 extension trial data (two-thirds of weight back within one year) Pattern 2: Partial regain with stabilization (approximately 45% of discontinuations)
Your program also includes: Monthly provider check-ins (in-person or virtual) Nutritionist consultation Tracking of visceral fat and muscle mass via body composition monitoring (available in Bend & Seattle) Our goal is to support healthy, long-term results while preserving strength and overall wellness
The simple way to put it is that BPC-157 builds the new blood vessels, and TB-500 mobilizes the repair cells to use them
By inhibiting macrophage infiltration, calcium deposition, extracellular matrix remodeling and the proliferation of vascular smooth muscle cells
In contrast, prescription drugs such as Ozempic undergo rigorous FDA evaluations to confirm their safety and proper dosing
BPC-157 is recognized for its anti-inflammatory properties that aid in tissue repair and inflammation reduction, while VIP acts as a potent anti-inflammatory agent, modulating immune responses